tiprankstipranks
Trending News
More News >
Britannia Life Sciences Inc (TSE:BLAB)
:BLAB
Canadian Market

Britannia Life Sciences Inc (BLAB) Ratios

Compare
2 Followers

Britannia Life Sciences Inc Ratios

TSE:BLAB's free cash flow for Q2 2025 was C$0.58. For the 2025 fiscal year, TSE:BLAB's free cash flow was decreased by C$ and operating cash flow was C$-1.91. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.00 2.72 0.26 0.92 0.42
Quick Ratio
1.00 2.72 0.24 0.92 0.42
Cash Ratio
0.29 2.15 0.13 0.57 0.20
Solvency Ratio
1.55 1.40 -0.28 0.43 -0.98
Operating Cash Flow Ratio
-1.46 -0.72 0.20 0.26 0.34
Short-Term Operating Cash Flow Coverage
-26.06 -20.32 0.99 0.61 0.57
Net Current Asset Value
C$ -2.23MC$ 4.62MC$ -12.86MC$ -8.27MC$ -12.12M
Leverage Ratios
Debt-to-Assets Ratio
0.23 0.16 0.33 0.36 0.25
Debt-to-Equity Ratio
0.48 0.29 2.99 1.20 3.84
Debt-to-Capital Ratio
0.32 0.23 0.75 0.54 0.79
Long-Term Debt-to-Capital Ratio
0.30 0.20 0.66 0.47 0.08
Financial Leverage Ratio
2.04 1.84 9.13 3.35 15.59
Debt Service Coverage Ratio
15.91 -18.69 -0.54 2.44 -1.59
Interest Coverage Ratio
7.79 -21.19 0.13 0.21 0.16
Debt to Market Cap
0.14 0.14 0.61 0.54 0.24
Interest Debt Per Share
0.01 0.01 0.05 0.06 0.07
Net Debt to EBITDA
-0.34 1.36 -3.15 0.84 -0.33
Profitability Margins
Gross Profit Margin
78.47%7.40%64.12%72.43%72.08%
EBIT Margin
151.12%-1206.25%-29.39%104.81%-150.15%
EBITDA Margin
153.55%-1189.96%-25.05%108.61%-147.55%
Operating Profit Margin
117.15%-609.28%2.29%2.78%5.20%
Pretax Profit Margin
136.12%-1235.00%-59.00%91.48%-181.84%
Net Profit Margin
-276.74%2001.95%-62.99%79.39%-211.76%
Continuous Operations Profit Margin
131.58%-1235.00%-58.11%91.45%-191.59%
Net Income Per EBT
-203.31%-162.10%106.76%86.78%116.45%
EBT Per EBIT
116.19%202.70%-2581.41%3295.78%-3497.28%
Return on Assets (ROA)
79.73%63.67%-21.42%21.59%-73.30%
Return on Equity (ROE)
181.92%117.33%-195.58%72.39%-1142.96%
Return on Capital Employed (ROCE)
-47.72%-28.27%1.47%0.94%2.97%
Return on Invested Capital (ROIC)
-44.61%-27.58%1.22%0.84%2.26%
Return on Tangible Assets
79.73%63.67%-114.03%85.57%-383.50%
Earnings Yield
48.27%60.75%-41.98%33.00%-74.30%
Efficiency Ratios
Receivables Turnover
-1.38 1.62 6.26 4.01 4.07
Payables Turnover
-0.47 0.15 1.14 0.78 0.69
Inventory Turnover
0.00 0.00 14.73 0.00 0.00
Fixed Asset Turnover
-26.47 2.58 10.49 14.16 13.37
Asset Turnover
-0.29 0.03 0.34 0.27 0.35
Working Capital Turnover Ratio
-1.08 -0.49 -1.86 -2.46 -1.17
Cash Conversion Cycle
515.83 -2.13K -238.26 -375.43 -440.89
Days of Sales Outstanding
-265.06 225.47 58.30 91.04 89.62
Days of Inventory Outstanding
0.00 0.00 24.78 0.00 0.00
Days of Payables Outstanding
-780.89 2.36K 321.34 466.47 530.52
Operating Cycle
-265.06 225.47 83.07 91.04 89.62
Cash Flow Ratios
Operating Cash Flow Per Share
-0.03 -0.02 0.01 <0.01 0.03
Free Cash Flow Per Share
-0.03 -0.02 0.01 <0.01 0.02
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.02 1.00 0.84 0.72 0.97
Dividend Paid and CapEx Coverage Ratio
-42.65 -654.90K 6.20 3.55 32.15
Capital Expenditure Coverage Ratio
-42.65 -654.90K 6.20 3.55 32.15
Operating Cash Flow Coverage Ratio
-1.82 -1.41 0.29 0.14 0.54
Operating Cash Flow to Sales Ratio
1.48 -7.09 0.28 0.19 0.38
Free Cash Flow Yield
-26.42%-21.53%15.44%5.68%13.04%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
1.97 1.65 -2.38 3.03 -1.35
Price-to-Sales (P/S) Ratio
-5.46 32.95 1.50 2.41 2.85
Price-to-Book (P/B) Ratio
3.21 1.93 4.66 2.19 15.38
Price-to-Free Cash Flow (P/FCF) Ratio
-3.60 -4.65 6.47 17.62 7.67
Price-to-Operating Cash Flow Ratio
-3.69 -4.65 5.43 12.66 7.43
Price-to-Earnings Growth (PEG) Ratio
0.18 -0.81 0.01 -0.02 >-0.01
Price-to-Fair Value
3.21 1.93 4.66 2.19 15.38
Enterprise Value Multiple
-3.90 -1.41 -9.13 3.05 -2.26
Enterprise Value
18.59M 6.18M 17.32M 21.21M 24.37M
EV to EBITDA
-4.07 -1.41 -9.13 3.05 -2.26
EV to Sales
-6.26 16.73 2.29 3.31 3.34
EV to Free Cash Flow
-4.13 -2.36 9.88 24.26 8.98
EV to Operating Cash Flow
-4.23 -2.36 8.28 17.44 8.70
Tangible Book Value Per Share
0.03 0.04 -0.07 -0.04 -0.11
Shareholders’ Equity Per Share
0.03 0.04 0.02 0.04 0.01
Tax and Other Ratios
Effective Tax Rate
0.03 0.00 0.02 <0.01 -0.05
Revenue Per Share
-0.02 <0.01 0.05 0.04 0.07
Net Income Per Share
0.05 0.05 -0.03 0.03 -0.14
Tax Burden
-2.03 -1.62 1.07 0.87 1.16
Interest Burden
0.90 1.02 2.01 0.87 1.21
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
-0.48 5.39 0.43 0.53 1.84
Stock-Based Compensation to Revenue
0.00 0.00 0.03 0.16 0.15
Income Quality
1.12 0.57 -0.44 0.21 -0.20
Currency in CAD